We prepared and characterized a series of 11尾-(4-Substituted phenyl) estradiol analogs using modifications of existing synthetic methods. The new compounds, as well as standard steroidal agonists and antagonists, were evaluated as competitive ligands for the ER尾-LBD. Functional assays used the induction of alkaline phosphatase in Ishikawa cells to determine potency of the compounds as ER agonists or antagonists.
The synthetic strategy successfully generated a series of compounds in which the 4-substituent was sequentially modified from hydroxyl to methoxy to azidoethoxy/N,N-dimethylaminoethoxy and eventually to a prototypical 1,4-naphthoquinone-containing moiety. The new compounds all retained high relative binding affinity (RBA) for the ER伪-LBD, ranging from 13-83%that of estradiol. No subtype selectivity was observed. More importantly, the transition from agonist to antagonist activity occurs at the 4-methoxy stage where the compound is a mixed antagonist. More notably, antagonism appeared to be more dependent upon the size of the 11尾-substituent than upon the nature of the terminal group
We have developed a synthetic strategy that provides facile access to potent 11尾-(4-substituted phenyl) estradiol analogs. The resultant compounds retain high affinity for the ER伪-LBD and, more importantly, demonstrate potent antagonist activity in cells. Large functionalities distal to the 11尾-phenyl ring had little additional effect on either affinity or efficacy, suggesting the incorporation of diverse imaging or biologically active groups can be attached without significantly compromising the ER-binding capacity. Future studies are in progress to exploit the 11尾-aryl estradiol analogs as potential drug delivery systems and imaging agents.